表紙:ドライアイ治療薬の世界市場:産業分析、市場規模・シェア・成長率・動向・予測 (2020~2030年)
市場調査レポート
商品コード
953644

ドライアイ治療薬の世界市場:産業分析、市場規模・シェア・成長率・動向・予測 (2020~2030年)

Dry Eye Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

出版日: | 発行: Transparency Market Research | ページ情報: 英文 214 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.10円
ドライアイ治療薬の世界市場:産業分析、市場規模・シェア・成長率・動向・予測 (2020~2030年)
出版日: 2020年06月18日
発行: Transparency Market Research
ページ情報: 英文 214 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のドライアイ治療薬の市場について分析し、市場の基本構造や主な影響要因、市場規模の動向見通し (過去2年間・今後11年間分)、製品別・疾患別・流通チャネル別および地域別の詳細動向、競争環境 (市場シェア構造)、主要企業のプロファイルなどを調査しております。

目次

第1章 序文

第2章 前提条件と分析方法

第3章 エグゼクティブサマリー:世界のドライアイ治療薬市場

第4章 市場概要

  • イントロダクション
    • 種類の定義
    • 業界の進化/発展
  • 概要
  • 市場のダイナミクス
    • 促進要因
    • 抑制要因
    • 市場機会
  • 世界のドライアイ治療薬市場の分析・予測 (2018~2030年)
    • 市場収益額の予測 (金額ベース)
  • ポーターのファイブフォース分析

第5章 主な洞察

  • 世界のドライアイ治療薬市場:主な企業合併・買収 (M&A)
  • パイプライン分析
  • 世界の主要国における疾患の有病率と発生率
  • 技術進歩
  • 新型コロナウイルス感染症 (COVID-19) の業界への影響 (短期的/中期的/長期的影響)

第6章 世界のドライアイ治療薬市場の分析・予測:製品別

  • イントロダクションと定義
  • 市場規模の予測:製品別 (2018~2030年)
    • 人工涙液
    • 抗炎症薬
    • 涙点プラグ
    • 秘書
    • 分泌促進剤
  • 市場求心力の分析:製品別

第7章 世界のドライアイ治療薬市場の分析・予測:疾患別

  • イントロダクションと定義
  • 市場規模の予測:疾患別 (2018~2030年)
    • 蒸発亢進型ドライアイ症候群
    • 涙液減少型ドライアイ症候群
  • 市場求心力の分析:疾患別

第8章 世界のドライアイ治療薬市場の分析・予測:流通チャネル別

  • イントロダクションと定義
  • 市場規模の予測:流通チャネル別 (2018~2030年)
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場求心力の分析:流通チャネル別

第9章 世界のドライアイ治療薬市場の分析・予測:地域別

  • 主な調査結果
  • 市場規模の予測:地域別
    • 北米
    • 欧州
    • アジア太平洋市場
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場求心力の分析:地域別

第10章 北米のドライアイ治療薬市場の分析・予測

  • イントロダクション
    • 主な調査結果
  • 市場規模の予測:製品別 (金額ベース、2018~2030年)
  • 市場規模の予測:疾患別 (金額ベース、2018~2030年)
  • 市場規模の予測:流通チャネル別 (金額ベース、2018~2030年)
  • 市場規模の予測:国別 (金額ベース、2018~2030年)
    • 米国
    • カナダ
  • 北米のドライアイ治療薬市場:求心力の分析

第11章 欧州のドライアイ治療薬市場の分析・予測

第12章 アジア太平洋地域のドライアイ治療薬市場の分析・予測

第13章 ラテンアメリカのドライアイ治療薬市場の分析・予測

第14章 中東・アフリカのドライアイ治療薬市場の分析・予測

第15章 競合情勢

  • 市場参入企業:競合マトリックス(企業階層別・規模別)
  • 市場シェア/ポジション分析:企業別 (2018年)
  • 各企業のビジネス戦略
  • 企業プロファイル
    • Novartis AG
    • Allergan
    • 参天製薬
    • OASIS Medical
    • Sun Pharmaceutical Industries Ltd.
    • Johnson & Johnson
    • 大塚製薬
    • Sentiss Pharma Pvt. Ltd.
    • RegeneRx (ReGenTree, LLC)
    • Bausch Health Companies, Inc.
図表

List of Tables

  • Table 1: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 2: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 3: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 4: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 5: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 6: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 7: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 8: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 9: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 10: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 11: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 12: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 13: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 14: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 15: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 16: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 17: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 18: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 19: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 20: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 21: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 22: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 23: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 24: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 25: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 26: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 27: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 28: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 29: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 30: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030

List of Figures

  • Figure 01: Global Dry Eye Disease Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2030
  • Figure 02: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 03: Global Dry Eye Disease Treatment Market Value Share (%), by Product, 2019
  • Figure 04: Global Dry Eye Disease Treatment Market Value Share (%), by Disease, 2019
  • Figure 05: Global Dry Eye Disease Treatment Market Value Share (%), by Distribution Channel, 2019
  • Figure 06: Global Dry Eye Disease Treatment Market Value Share (%), by Region, 2019
  • Figure 07: Global Dry Eye Disease Treatment Market Value Share Analysis (%), by Product, 2019 and 2030
  • Figure 08: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 09: Global Dry Eye Disease Treatment Market Value Share (%), by Anti-inflammatory, 2019 and 2030
  • Figure 10: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Tears, 2018-2030
  • Figure 11: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anti-inflammatory, 2018-2030
  • Figure 12: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Secretagogue, 2018-2030
  • Figure 13: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Punctal Plugs, 2018-2030
  • Figure 14: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2030
  • Figure 15: Global Dry Eye Disease Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030
  • Figure 16: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 17: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Evaporative Dry Eye Syndrome, 2018-2030
  • Figure 18: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aqueous Dry Eye Syndrome, 2018-2030
  • Figure 19: Global Dry Eye Disease Treatment Market Value Share (%)Analysis, by Distribution Channel, 2019 and 2030
  • Figure 20: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 21: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030
  • Figure 22: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030
  • Figure 23: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018-2030
  • Figure 24: Global Dry Eye Disease Treatment Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 25: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 26: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 27: North America Dry Eye Disease Treatment Market Value Share Analysis, by Country, 2019 and 2027
  • Figure 28: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 29: North America Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 30: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 31: North America Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 32: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 33: North America Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 34: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 35: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 36: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 37: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 38: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 39: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 40: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 41: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 42: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 43: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 44: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 45: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 46: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 47: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 48: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 49: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 50: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 51: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 52: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 53: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 54: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 55: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 56: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 57: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 58: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 59: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 60: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 61: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 62: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 63: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 64: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 65: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 66: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 67: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 68: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 69: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 70: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
目次
Product Code: TMRGL77640

Title:
Dry Eye Disease Treatment Market (Product: Artificial Tears, Anti-inflammatory [Cyclosporine, Corticosteroid, and Others], Punctal Plugs, Secretagogue, and Others; Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030.

Scope of the Report

TMR's report on the global dry eye disease treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global dry eye disease treatment market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global dry eye disease treatment market during the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global dry eye disease treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, companies' presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global dry eye disease treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global dry eye disease treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global dry eye disease treatment market.

The report delves into the competition landscape of the global dry eye disease treatment market. Key players operating in the global dry eye disease treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global dry eye disease treatment market that have been profiled in this report.

Key Questions Answered:

  • What is the scope of growth of the anti-inflammatory segment of the global dry eye disease treatment market?
  • What will be the Y-o-Y growth of the global dry eye disease treatment market between 2020 and 2030?
  • What is the influence of changing trends in cyclosporine on the global dry eye disease treatment market?
  • Will North America continue to be the most profitable market for dry eye disease drug providers?
  • Which factors are anticipated to hamper the growth of the global dry eye disease treatment market during the forecast period?
  • Which are the leading companies in the global dry eye disease treatment market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global dry eye disease treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global dry eye disease treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the global dry eye disease treatment market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the dry eye disease treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global dry eye disease treatment market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global dry eye disease treatment market more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Dry Eye Disease Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Dry Eye Disease Treatment Market Analysis and Forecast, 2018-2030
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Global Dry Eye Disease Treatment Market: Key Mergers & Acquisitions
  • 5.2. Pipeline Analysis
  • 5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
  • 5.4. Technological Advancement
  • 5.5. COVID-19 Pandemics Impact on Industry (Short / Mid / Long Term Impact)

6. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
    • 6.1.1. Key Findings / Developments
  • 6.2. Global Dry Eye Disease Treatment Market Value Forecast, by Product, 2018-2030
    • 6.2.1. Artificial Tears
    • 6.2.2. Anti-inflammatory
      • 6.2.2.1. Cyclosporine
      • 6.2.2.2. Corticosteroid
      • 6.2.2.3. Others
    • 6.2.3. Punctal Plugs
    • 6.2.4. Secretagogue
    • 6.2.5. Others
  • 6.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product

7. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Disease

  • 7.1. Introduction & Definition
    • 7.1.1. Key Findings / Developments
  • 7.2. Global Dry Eye Disease Treatment Market Value Forecast, by Disease, 2018-2030
    • 7.2.1. Evaporative Dry Eye Syndrome
    • 7.2.2. Aqueous Dry Eye Syndrome
  • 7.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease

8. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
    • 8.1.1. Key Findings / Developments
  • 8.2. Global Dry Eye Disease Treatment Market Value Forecast, by Distribution Channel, 2018-2030
    • 8.2.1. Hospital Pharmacies
    • 8.2.2. Retail Pharmacies
    • 8.2.3. Online Pharmacies
  • 8.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel

9. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Dry Eye Disease Treatment Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Region

10. North America Dry Eye Disease Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 10.2.1. Artificial Tears
    • 10.2.2. Anti-inflammatory
      • 10.2.2.1. Cyclosporine
      • 10.2.2.2. Corticosteroid
      • 10.2.2.3. Others
    • 10.2.3. Punctal Plugs
    • 10.2.4. Secretagogue
    • 10.2.5. Others
  • 10.3. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
    • 10.3.1. Evaporative Dry Eye Syndrome
    • 10.3.2. Aqueous Dry Eye Syndrome
  • 10.4. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018-2030
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Dry Eye Disease Treatment Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Disease
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Dry Eye Disease Treatment Market Analysis and Forecast

  • 11.1. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 11.1.1. Artificial Tears
    • 11.1.2. Anti-inflammatory
      • 11.1.2.1. Cyclosporine
      • 11.1.2.2. Corticosteroid
      • 11.1.2.3. Others
    • 11.1.3. Punctal Plugs
    • 11.1.4. Secretagogue
    • 11.1.5. Others
  • 11.2. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
    • 11.2.1. Evaporative Dry Eye Syndrome
    • 11.2.2. Aqueous Dry Eye Syndrome
  • 11.3. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. Online Pharmacies
  • 11.4. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 11.4.1. Germany
    • 11.4.2. U.K.
    • 11.4.3. France
    • 11.4.4. Spain
    • 11.4.5. Italy
    • 11.4.6. Rest of Europe
  • 11.5. Europe Dry Eye Disease Treatment Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Disease
    • 11.5.3. By Distribution Channel
    • 11.5.4. By Country/Sub-region

12. Asia Pacific Dry Eye Disease Treatment Market Analysis and Forecast

  • 12.1. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 12.1.1. Artificial Tears
    • 12.1.2. Anti-inflammatory
      • 12.1.2.1. Cyclosporine
      • 12.1.2.2. Corticosteroid
      • 12.1.2.3. Others
    • 12.1.3. Punctal Plugs
    • 12.1.4. Secretagogue
    • 12.1.5. Others
  • 12.2. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
    • 12.2.1. Evaporative Dry Eye Syndrome
    • 12.2.2. Aqueous Dry Eye Syndrome
  • 12.3. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 12.4.1. China
    • 12.4.2. Japan
    • 12.4.3. India
    • 12.4.4. Australia & New Zealand
    • 12.4.5. Rest of Asia Pacific
  • 12.5. Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Disease
    • 12.5.3. By Distribution Channel
    • 12.5.4. By Country/Sub-region

13. Latin America Dry Eye Disease Treatment Market Analysis and Forecast

  • 13.1. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 13.1.1. Artificial Tears
    • 13.1.2. Anti-inflammatory
      • 13.1.2.1. Cyclosporine
      • 13.1.2.2. Corticosteroid
      • 13.1.2.3. Others
    • 13.1.3. Punctal Plugs
    • 13.1.4. Secretagogue
    • 13.1.5. Others
  • 13.2. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
    • 13.2.1. Evaporative Dry Eye Syndrome
    • 13.2.2. Aqueous Dry Eye Syndrome
  • 13.3. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 13.3.1. Hospital Pharmacies
    • 13.3.2. Retail Pharmacies
    • 13.3.3. Online Pharmacies
  • 13.4. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 13.4.1. Brazil
    • 13.4.2. Mexico
    • 13.4.3. Rest of Latin America Latin America
  • 13.5. Latin America Dry Eye Disease Treatment Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By Disease
    • 13.5.3. By Distribution Channel
    • 13.5.4. By Country/Sub-region

14. Middle East & Africa Dry Eye Disease Treatment Market Analysis and Forecast

  • 14.1.1.
  • 14.2. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 14.2.1. Artificial Tears
    • 14.2.2. Anti-inflammatory
      • 14.2.2.1. Cyclosporine
      • 14.2.2.2. Corticosteroid
      • 14.2.2.3. Others
    • 14.2.3. Punctal Plugs
    • 14.2.4. Secretagogue
    • 14.2.5. Others
  • 14.3. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 14.3.1. Evaporative Dry Eye Syndrome
    • 14.3.2. Aqueous Dry Eye Syndrome
  • 14.4. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Disease
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competitive Landscape

  • 15.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 15.2. Market Share / Position Analysis, by Company, 2018
  • 15.3. Competitive Business Strategies
  • 15.4. Company Profiles
    • 15.4.1. Novartis AG
      • 15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.1.2. Growth Strategies
      • 15.4.1.3. SWOT Analysis
    • 15.4.2. Allergan
      • 15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.2.2. Growth Strategies
      • 15.4.2.3. SWOT Analysis
    • 15.4.3. Santen Pharmaceutical Co., Ltd.
      • 15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.3.2. Growth Strategies
      • 15.4.3.3. SWOT Analysis
    • 15.4.4. OASIS Medical
      • 15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.4.2. Growth Strategies
      • 15.4.4.3. SWOT Analysis
    • 15.4.5. Sun Pharmaceutical Industries Ltd.
      • 15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.5.2. Growth Strategies
      • 15.4.5.3. SWOT Analysis
    • 15.4.6. Johnson & Johnson
      • 15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.6.2. Growth Strategies
      • 15.4.6.3. SWOT Analysis
    • 15.4.7. Otsuka Pharmaceutical Co., Ltd.
      • 15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.7.2. Growth Strategies
      • 15.4.7.3. SWOT Analysis
    • 15.4.8. Sentiss Pharma Pvt. Ltd.
      • 15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.8.2. Growth Strategies
      • 15.4.8.3. SWOT Analysis
    • 15.4.9. RegeneRx (ReGenTree, LLC)
      • 15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.9.2. Growth Strategies
      • 15.4.9.3. SWOT Analysis
    • 15.4.10. Bausch Health Companies, Inc.
      • 15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.10.2. Growth Strategies
      • 15.4.10.3. SWOT Analysis